Ocugen OCGN
NASDAQ OCGN
$1.00 -0.03 (-2.91%)
As of: Oct 1, 2026 · 3:59 PM EDT

Ocugen (OCGN) Cash from Financing Activities (2014 - 2026)

Updated

Ocugen's Cash from Financing Activities was $80.37 million in Q2 2026, compared with $61,000 a year earlier and up 129.7% from the prior quarter.

Analysis

Ocugen (OCGN) Cash from Financing Activities (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ocugen's Cash from Financing Activities was $133.86 million through Jun 30, 2026, up 109.9% year-over-year; for FY2025, it came in at $17.33 million, down 73.3% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -11.3% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $64.86 million in FY2024 (+210.6%), $20.88 million in FY2023 (-64.9%), $59.48 million in FY2022 (-50.7%) and $120.68 million in FY2021 (+281.8%).
  • The Q2 2026 figure marks the highest quarterly Cash from Financing Activities since Q2 2021.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q3 2022 (growth of 774.5%); the worst was Q4 2025 (a decline of 100.0%).
  • Per Business Quant data, OCGN's Cash from Financing Activities in the three quarters before Q2 2026 was $34.98 million (Q1 2026), $2,000 (Q4 2025) and $18.51 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Ocugen 349.22 Mn 165.73 Mn - 80.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.37 Mn
Mar 31, 2026 34.98 Mn
Dec 31, 2025 2,000.00
Sep 30, 2025 18.51 Mn
Jun 30, 2025 61,000.00
Mar 31, 2025 -1.25 Mn
Dec 31, 2024 30.17 Mn
Sep 30, 2024 34.79 Mn
Jun 30, 2024 45,000.00
Mar 31, 2024 -145,000.00
Dec 31, 2023 16,000.00
Sep 30, 2023 -35,000.00
Jun 30, 2023 15.40 Mn
Mar 31, 2023 5.50 Mn
Dec 31, 2022 8.18 Mn
Sep 30, 2022 962,000.00
Jun 30, 2022 236,000.00
Mar 31, 2022 50.10 Mn
Dec 31, 2021 605,000.00
Sep 30, 2021 110,000.00
API Access

Ocugen Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OCGN&period=max&api_key=YOUR_API_KEY